BACE1 and early-onset autosomal dominant Alzheimer disease: Furthermore, inhibition of lncRNA BC200 increased cell viability and reduced cell apoptosis in an Alzheimer’s disease model by directly targeting BACE1 (Li H. et al., 2018).